GLSI
Greenwich LifeSciences, Inc. NASDAQ Listed Sep 25, 2020$23.75
+1.58%
vs $23.38
Mkt Cap $309.1M
52w Low $7.85
61.8% of range
52w High $33.57
50d MA $24.78
200d MA $19.27
P/E (TTM)
-15.1x
EV/EBITDA
—
P/B
122.0x
Debt/Equity
0.0x
ROE
-790.5%
P/FCF
-42.5x
RSI (14)
29.70
ATR (14)
$1.91
Beta
1.53
50d MA
$24.78
200d MA
$19.27
Avg Volume
142.2K
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
Building 14 · Stafford, TX 77477 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | AMC | -0.32 | -0.32 | +0.0% | 24.02 | -0.7% | -4.4% | -0.6% | -3.5% | +2.2% | +7.5% | — |
| Nov 14, 2025 | AMC | -0.30 | -0.30 | +0.0% | 8.32 | +0.8% | -1.1% | +0.1% | -1.3% | +0.4% | -0.1% | — |
| Aug 14, 2025 | AMC | -0.24 | -0.30 | -25.0% | 12.08 | +1.0% | +0.7% | -1.3% | -4.5% | +4.1% | -0.8% | — |
| May 20, 2025 | AMC | -0.24 | -0.25 | -4.2% | 10.30 | -2.9% | -5.5% | +0.7% | +0.1% | +1.7% | -2.6% | — |
| Apr 15, 2025 | AMC | -0.21 | -0.61 | -190.5% | 8.95 | -0.7% | -1.2% | +1.2% | +4.4% | +3.1% | +2.3% | — |
| Nov 14, 2024 | AMC | -0.21 | -0.20 | +4.8% | 13.59 | +5.3% | -7.6% | -1.5% | +3.2% | +0.6% | +0.9% | — |
| Aug 14, 2024 | AMC | -0.20 | -0.20 | +0.0% | 12.99 | +3.9% | +4.5% | +2.4% | +2.0% | -2.6% | +7.1% | — |
| May 20, 2024 | AMC | -0.20 | -0.19 | +5.0% | 13.08 | +2.0% | +3.5% | -0.3% | -3.1% | +2.4% | -1.6% | — |
| Apr 15, 2024 | AMC | -0.20 | -0.21 | -5.0% | 14.26 | -3.4% | +1.1% | -9.5% | -1.2% | -6.4% | +5.1% | — |
| Oct 19, 2023 | AMC | -0.22 | -0.19 | +13.6% | 8.27 | -0.3% | +0.1% | -6.2% | +5.5% | -3.0% | +4.0% | — |
| Aug 21, 2023 | AMC | -0.23 | -0.13 | +43.5% | 10.15 | -5.2% | -1.5% | -0.7% | -3.7% | -2.8% | -0.9% | — |
| May 22, 2023 | AMC | -0.23 | -0.17 | +26.1% | 11.80 | +1.4% | -1.7% | -2.3% | -4.7% | +0.3% | +0.7% | — |
| Mar 31, 2023 | AMC | -0.18 | -0.22 | -22.2% | 13.79 | +1.7% | -4.3% | -2.7% | -0.7% | +2.9% | -3.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $24.78 | $25.93 | +4.6% | -11.5% | -4.2% | -7.3% | +8.9% | -3.2% |
| Apr 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.95 | $9.05 | +1.1% | +4.4% | +3.1% | +2.3% | +6.0% | -4.4% |
| Feb 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.23 | $12.04 | -1.6% | -1.8% | -0.3% | +2.8% | +0.7% | +1.2% |
| Aug 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.14 | $14.63 | +3.5% | +5.2% | -1.7% | -4.3% | -2.3% | +4.2% |
| May 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.54 | $13.86 | +2.4% | -0.3% | -3.1% | +2.4% | -1.6% | -0.2% |
| Feb 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.50 | $12.43 | -0.6% | -3.4% | +0.7% | +6.9% | -0.3% | -3.0% |
| Feb 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.24 | $11.40 | +1.4% | +15.1% | +1.7% | +1.8% | -3.5% | -6.6% |
| Apr 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.13 | $13.10 | -0.2% | -3.7% | -3.5% | -5.4% | +3.6% | -1.3% |
| Sep 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $40.02 | $42.00 | +4.9% | +9.3% | +1.7% | -1.2% | +1.9% | -2.1% |
| Jan 27 | Aegis Capital | Maintains | Buy → Buy | — | $36.54 | $36.65 | +0.3% | -6.4% | +0.0% | +9.6% | -4.2% | +1.4% |
| Jan 26 | Aegis Capital | Maintains | Buy → Buy | — | $36.16 | $36.25 | +0.2% | +1.1% | -6.4% | +0.0% | +9.6% | -4.2% |
No insider trades available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 298,266 | $7M | New | Mar 2026 |
| 2 | Nuveen, Llc | 88,717 | $2M | New | Mar 2026 |
| 3 | Northern Trust Corp | 75,125 | $2M | Added | Mar 2026 |
| 4 | Vanguard Portfolio Management Llc | 58,911 | $1M | New | Mar 2026 |
| 5 | Bank Of New York Mellon Corp | 46,523 | $1M | Added | Mar 2026 |
| 6 | Morgan Stanley | 52,758 | $1M | Added | Dec 2025 |
| 7 | Russell Investments Group, Ltd. | 39,697 | $954K | Added | Mar 2026 |
| 8 | Sei Investments Co | 26,088 | $627K | New | Mar 2026 |
| 9 | Marshall Wace, Llp | 25,658 | $616K | New | Mar 2026 |
| 10 | Informed Momentum Co Llc | 21,430 | $515K | New | Mar 2026 |
| 11 | Ubs Group Ag | 21,116 | $507K | Added | Mar 2026 |
| 12 | Millennium Management | 17,398 | $418K | New | Mar 2026 |
| 13 | Raymond James Financial Inc | 9,837 | $236K | New | Mar 2026 |
| 14 | Jane Street Group, Llc | 9,677 | $203K | New | Dec 2025 |
| 15 | Strs Ohio | 5,700 | $120K | Reduced | Dec 2025 |
| 16 | Fmr Llc | 4,107 | $99K | Added | Mar 2026 |
| 17 | Police & Firemen's Retirement System Of New Jersey | 2,768 | $66K | — | Mar 2026 |
| 18 | Wells Fargo & Company/mn | 2,440 | $59K | New | Mar 2026 |
| 19 | Jpmorgan Chase & Co | 2,604 | $56K | Reduced | Mar 2026 |
| 20 | Bnp Paribas Financial Markets | 1,732 | $42K | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$309.1M
Enterprise Value
$305.0M
P/E (TTM)
-15.13x
Forward P/E
—
PEG Ratio
-0.12x
P/B
121.98x
P/S
—
P/FCF
-42.54x
EV/EBITDA
—
Shares Out
13.0M
Financials (TTM)
Revenue
$0
Net Income
-$21.8M
EBITDA
-$21.8M
Free Cash Flow
-$7.3M
Op Cash Flow
-$7.3M
EPS Basic
$-1.21
EPS Diluted
$-1.57
EPS Forward
$-1.35
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$4.1M
Total Liab.
$1.6M
Total Equity
$2.5M
Cash
$4.1M
LT Debt
$0
Book Value/Sh
$0.19
Debt/Equity
0.00x
Current Ratio
2.62
Quick Ratio
2.62
Returns & Growth
ROE
-790.5%
ROA
-453.7%
ROIC
-631.9%
Rev Growth YoY
+0.0%
EPS Growth YoY
-75.4%
Price Returns
2W
+0.8%
1M
+10.8%
3M
-5.6%
6M
+199.8%
12M
+165.7%
Technicals
52W High
$33.57
52W Low
$7.85
50d MA
$24.78
200d MA
$19.27
RSI (14)
29.70
ATR (14)
$1.91
Beta
1.53
Avg Volume
142K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$50.00
High
$50.00
Low
$50.00
Median
$50.00
Data updated apr 25, 2026 11:42am
· Source: financialmodelingprep.com